Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, sale, and high-value medical consumables in China. The company provides products for orthopedics, minimally invasive surgery, neurosurgery, wound surgery, and dentistry, etc. It also exports its products to various countries and regions. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Compa… Read more
Double Medical Technology Inc (002901) - Total Assets
Latest total assets as of September 2025: CN¥4.55 Billion CNY
Based on the latest financial reports, Double Medical Technology Inc (002901) holds total assets worth CN¥4.55 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Double Medical Technology Inc - Total Assets Trend (2013–2024)
This chart illustrates how Double Medical Technology Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Double Medical Technology Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Double Medical Technology Inc's total assets of CN¥4.55 Billion consist of 63.6% current assets and 36.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 24.4% |
| Accounts Receivable | CN¥245.54 Million | 5.6% |
| Inventory | CN¥1.27 Billion | 28.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥125.61 Million | 2.8% |
| Goodwill | CN¥67.77 Million | 1.5% |
Asset Composition Trend (2013–2024)
This chart illustrates how Double Medical Technology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Double Medical Technology Inc's current assets represent 63.6% of total assets in 2024, an increase from 63.0% in 2013.
- Cash Position: Cash and equivalents constituted 24.4% of total assets in 2024, up from 12.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 10.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 28.8% of total assets.
Double Medical Technology Inc Competitors by Total Assets
Key competitors of Double Medical Technology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
JVM Co. Ltd
KQ:054950
|
Korea | ₩296.91 Billion |
Double Medical Technology Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Double Medical Technology Inc generates 0.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Double Medical Technology Inc generates $8.07 in net profit.
Double Medical Technology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.77 | 3.16 | 4.47 |
| Quick Ratio | 2.16 | 1.77 | 3.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.19 Billion | CN¥ 1.97 Billion | CN¥ 1.53 Billion |
Double Medical Technology Inc - Advanced Valuation Insights
This section examines the relationship between Double Medical Technology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.89 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | -4.8% |
| Total Assets | CN¥4.42 Billion |
| Market Capitalization | $404.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Double Medical Technology Inc's assets below their book value (0.09 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Double Medical Technology Inc's assets decreased by 4.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Double Medical Technology Inc (2013–2024)
The table below shows the annual total assets of Double Medical Technology Inc from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.42 Billion | -4.76% |
| 2023-12-31 | CN¥4.64 Billion | +17.83% |
| 2022-12-31 | CN¥3.94 Billion | +16.50% |
| 2021-12-31 | CN¥3.38 Billion | +28.14% |
| 2020-12-31 | CN¥2.64 Billion | +17.81% |
| 2019-12-31 | CN¥2.24 Billion | +34.46% |
| 2018-12-31 | CN¥1.67 Billion | +19.93% |
| 2017-12-31 | CN¥1.39 Billion | +93.08% |
| 2016-12-31 | CN¥719.06 Million | +28.10% |
| 2015-12-31 | CN¥561.32 Million | +2.94% |
| 2014-12-31 | CN¥545.28 Million | +84.10% |
| 2013-12-31 | CN¥296.19 Million | -- |